Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ib alpha

被引:59
作者
Miyata, S
Goto, S
Federici, AB
Ware, J
Ruggeri, ZM
机构
[1] SCRIPPS RES INST, ROON RES CTR ARTERIOSCLEROSIS & THROMBOSIS, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA
[2] Scripps Res Inst, ROON RES CTR ARTERIOSCLEROSIS & THROMBOSIS, DEPT VASC BIOL, LA JOLLA, CA 92037 USA
关键词
D O I
10.1074/jbc.271.15.9046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction between von Willebrand factor (vWF) Al domain and platelet glycoprotein Ib alpha occurs in the presence of high shear stress or when vWF becomes immobilized onto a surface but not appreciably in the normal circulation, To investigate the structural properties regulating Al domain function, we have used recombinant fragments prepared either in cyclic form with oxidized Cys(509)-Cys(695) disulfide bond or reduced and alkylated. Interaction with glycoprotein Ib alpha was assessed by testing inhibition of monoclonal antibody LJ-Ib1 binding to platelets and inhibition of shear-induced platelet aggregation mediated by native vWF. Fragments exposed to pH between 2.5 and 3.5 adopted the molten globule conformation with loosened tertiary structure intermediate between native and completely unordered state, Maximal receptor binding activity was observed when fragments kept at acidic pH, particularly after reduction of the Cys(509)-Cys(695) disulfide bond, were subjected to quick refolding by rapid pH increase, In contrast, slow refolding by incremental pH change over several hours resulted in at least 20-fold lower activity. A specific single point mutation (I546V) resulted in enhanced receptor binding, whereas another mutation (S561G) caused markedly reduced binding, These results provide experimental evidence that conformational transitions can modulate function of the VWF Al domain in solution.
引用
收藏
页码:9046 / 9053
页数:8
相关论文
共 49 条
[1]  
ALEVRIADOU BR, 1993, BLOOD, V81, P1263
[2]   CROSS-LINKING OF A MONOMERIC 39/34-KDA DISPASE FRAGMENT OF VONWILLEBRAND-FACTOR (LEU-480/VAL-481-GLY-718) TO THE N-TERMINAL REGION OF THE ALPHA-CHAIN OF MEMBRANE GLYCOPROTEIN-IB ON INTACT PLATELETS WITH BIS(SULFOSUCCINIMIDYL) SUBERATE [J].
ANDREWS, RK ;
GORMAN, JJ ;
BOOTH, WJ ;
CORINO, GL ;
CASTALDI, PA ;
BERNDT, MC .
BIOCHEMISTRY, 1989, 28 (21) :8326-8336
[3]  
AZUMA H, 1993, J BIOL CHEM, V268, P2821
[4]  
AZUMA H, 1991, J BIOL CHEM, V266, P12342
[5]   PREVENTION OF OCCLUSIVE CORONARY-ARTERY THROMBOSIS BY A MURINE MONOCLONAL-ANTIBODY TO PORCINE VONWILLEBRAND-FACTOR [J].
BELLINGER, DA ;
NICHOLS, TC ;
READ, MS ;
REDDICK, RL ;
LAMB, MA ;
BRINKHOUS, KM ;
EVATT, BL ;
GRIGGS, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) :8100-8104
[6]   IDENTIFICATION OF ASPARTIC ACID-514 THROUGH GLUTAMIC ACID-542 AS A GLYCOPROTEIN-IB-IX COMPLEX RECEPTOR RECOGNITION SEQUENCE IN VONWILLEBRAND-FACTOR - MECHANISM OF MODULATION OF VONWILLEBRAND-FACTOR BY RISTOCETIN AND BOTROCETIN [J].
BERNDT, MC ;
WARD, CM ;
BOOTH, WJ ;
CASTALDI, PA ;
MAZUROV, AV ;
ANDREWS, RK .
BIOCHEMISTRY, 1992, 31 (45) :11144-11151
[7]  
CORASH L, 1990, BLOOD CELLS, V16, P97
[8]  
CRUZ MA, 1993, J BIOL CHEM, V268, P21238
[9]   DISTINCT ABNORMALITIES IN THE INTERACTION OF PURIFIED TYPE-IIA AND TYPE-IIB VONWILLEBRAND-FACTOR WITH THE 2 PLATELET BINDING-SITES, GLYCOPROTEIN COMPLEX-IB-IX AND COMPLEX-IIB-IIIA [J].
DEMARCO, L ;
MAZZUCATO, M ;
DEROIA, D ;
CASONATO, A ;
FEDERICI, AB ;
GIROLAMI, A ;
RUGGERI, ZM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :785-792
[10]   ISOLATION OF PURE IGG1, IGG2A AND IGG2B IMMUNOGLOBULINS FROM MOUSE SERUM USING PROTEIN A-SEPHAROSE [J].
EY, PL ;
PROWSE, SJ ;
JENKIN, CR .
IMMUNOCHEMISTRY, 1978, 15 (07) :429-436